|
KO |
09100 Metabolism
|
|
|
09101 Carbohydrate metabolism
|
|
|
09102 Energy metabolism
|
|
|
09103 Lipid metabolism
|
|
|
09104 Nucleotide metabolism
|
00230 Purine metabolism [PATH:hsa00230]
|
53343 NUDT9; nudix hydrolase 9
56985 ADPRM; ADP-ribose/CDP-alcohol diphosphatase, manganese dependent
11164 NUDT5; nudix hydrolase 5
5236 PGM1; phosphoglucomutase 1
55276 PGM2; phosphoglucomutase 2
221823 PRPS1L1; phosphoribosyl pyrophosphate synthetase 1 like 1
5634 PRPS2; phosphoribosyl pyrophosphate synthetase 2
5631 PRPS1; phosphoribosyl pyrophosphate synthetase 1
5471 PPAT; phosphoribosyl pyrophosphate amidotransferase
2618 GART; phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
5198 PFAS; phosphoribosylformylglycinamidine synthase
10606 PAICS; phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
158 ADSL; adenylosuccinate lyase
471 ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
353 APRT; adenine phosphoribosyltransferase
22978 NT5C2; 5'-nucleotidase, cytosolic II
84618 NT5C1A; 5'-nucleotidase, cytosolic IA
93034 NT5C1B; 5'-nucleotidase, cytosolic IB
30833 NT5C; 5', 3'-nucleotidase, cytosolic
56953 NT5M; 5',3'-nucleotidase, mitochondrial
100526794 NT5C1B-RDH14; NT5C1B-RDH14 readthrough
284958 NT5DC4; 5'-nucleotidase domain containing 4
4907 NT5E; 5'-nucleotidase ecto
4860 PNP; purine nucleoside phosphorylase
144811 LACC1; laccase domain containing 1
3251 HPRT1; hypoxanthine phosphoribosyltransferase 1
3614 IMPDH1; inosine monophosphate dehydrogenase 1
3615 IMPDH2; inosine monophosphate dehydrogenase 2
10201 NME6; NME/NM23 nucleoside diphosphate kinase 6
29922 NME7; NME/NM23 family member 7
4831 NME2; NME/NM23 nucleoside diphosphate kinase 2
4833 NME4; NME/NM23 nucleoside diphosphate kinase 4
4830 NME1; NME/NM23 nucleoside diphosphate kinase 1
4832 NME3; NME/NM23 nucleoside diphosphate kinase 3
654364 NME1-NME2; NME1-NME2 readthrough
221264 AK9; adenylate kinase 9
956 ENTPD3; ectonucleoside triphosphate diphosphohydrolase 3
377841 ENTPD8; ectonucleoside triphosphate diphosphohydrolase 8
953 ENTPD1; ectonucleoside triphosphate diphosphohydrolase 1
124583 CANT1; calcium activated nucleotidase 1
9583 ENTPD4; ectonucleoside triphosphate diphosphohydrolase 4
957 ENTPD5; ectonucleoside triphosphate diphosphohydrolase 5 (inactive)
955 ENTPD6; ectonucleoside triphosphate diphosphohydrolase 6
131870 NUDT16; nudix hydrolase 16
3704 ITPA; inosine triphosphatase
7498 XDH; xanthine dehydrogenase
318 NUDT2; nudix hydrolase 2
8833 GMPS; guanine monophosphate synthase
2766 GMPR; guanosine monophosphate reductase
51292 GMPR2; guanosine monophosphate reductase 2
9615 GDA; guanine deaminase
2987 GUK1; guanylate kinase 1
6240 RRM1; ribonucleotide reductase catalytic subunit M1
50484 RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit M2B
6241 RRM2; ribonucleotide reductase regulatory subunit M2
51020 HDDC2; HD domain containing 2
1716 DGUOK; deoxyguanosine kinase
1633 DCK; deoxycytidine kinase
374659 HDDC3; HD domain containing 3
58497 PRUNE1; prune exopolyphosphatase 1
107 ADCY1; adenylate cyclase 1
108 ADCY2; adenylate cyclase 2
109 ADCY3; adenylate cyclase 3
196883 ADCY4; adenylate cyclase 4
111 ADCY5; adenylate cyclase 5
112 ADCY6; adenylate cyclase 6
113 ADCY7; adenylate cyclase 7
114 ADCY8; adenylate cyclase 8
115 ADCY9; adenylate cyclase 9
55811 ADCY10; adenylate cyclase 10
2977 GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2
2982 GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1
2983 GUCY1B1; guanylate cyclase 1 soluble subunit beta 1
2984 GUCY2C; guanylate cyclase 2C
3000 GUCY2D; guanylate cyclase 2D, retinal
2986 GUCY2F; guanylate cyclase 2F, retinal
4881 NPR1; natriuretic peptide receptor 1
4882 NPR2; natriuretic peptide receptor 2
5136 PDE1A; phosphodiesterase 1A
5153 PDE1B; phosphodiesterase 1B
5137 PDE1C; phosphodiesterase 1C
5138 PDE2A; phosphodiesterase 2A
5139 PDE3A; phosphodiesterase 3A
5140 PDE3B; phosphodiesterase 3B
8654 PDE5A; phosphodiesterase 5A
5145 PDE6A; phosphodiesterase 6A
5158 PDE6B; phosphodiesterase 6B
5146 PDE6C; phosphodiesterase 6C
5147 PDE6D; phosphodiesterase 6D
5148 PDE6G; phosphodiesterase 6G
5149 PDE6H; phosphodiesterase 6H
5152 PDE9A; phosphodiesterase 9A
10846 PDE10A; phosphodiesterase 10A
50940 PDE11A; phosphodiesterase 11A
122622 ADSS1; adenylosuccinate synthase 1
159 ADSS2; adenylosuccinate synthase 2
271 AMPD2; adenosine monophosphate deaminase 2
272 AMPD3; adenosine monophosphate deaminase 3
270 AMPD1; adenosine monophosphate deaminase 1
132 ADK; adenosine kinase
100 ADA; adenosine deaminase
51816 ADA2; adenosine deaminase 2
122481 AK7; adenylate kinase 7
205 AK4; adenylate kinase 4
26289 AK5; adenylate kinase 5
204 AK2; adenylate kinase 2
203 AK1; adenylate kinase 1
158067 AK8; adenylate kinase 8
102157402 AK6; adenylate kinase 6
50808 AK3; adenylate kinase 3
954 ENTPD2; ectonucleoside triphosphate diphosphohydrolase 2
84284 NTPCR; nucleoside-triphosphatase, cancer-related
5167 ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase 1
5169 ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase 3
5141 PDE4A; phosphodiesterase 4A
5142 PDE4B; phosphodiesterase 4B
5143 PDE4C; phosphodiesterase 4C
5144 PDE4D; phosphodiesterase 4D
5150 PDE7A; phosphodiesterase 7A
27115 PDE7B; phosphodiesterase 7B
8622 PDE8B; phosphodiesterase 8B
5151 PDE8A; phosphodiesterase 8A
2272 FHIT; fragile histidine triad diadenosine triphosphatase
22875 ENPP4; ectonucleotide pyrophosphatase/phosphodiesterase 4
9060 PAPSS2; 3'-phosphoadenosine 5'-phosphosulfate synthase 2
9061 PAPSS1; 3'-phosphoadenosine 5'-phosphosulfate synthase 1
646625 URAD; ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase
55821 ALLC; allantoicase
|
K13988 NUDT9; ADP-ribose diphosphatase [EC:3.6.1.13]
K01517 ADPRM; manganese-dependent ADP-ribose/CDP-alcohol diphosphatase [EC:3.6.1.13 3.6.1.16 3.6.1.53]
K13987 NUDT5; ADP-ribose diphosphatase / 8-oxo-dGDP phosphatase / ADP-D-ribose pyrophosphorylase [EC:3.6.1.13 3.6.1.58 2.7.7.96]
K01835 pgm; phosphoglucomutase [EC:5.4.2.2]
K15779 PGM2; phosphoglucomutase / phosphopentomutase [EC:5.4.2.2 5.4.2.7]
K00948 PRPS; ribose-phosphate pyrophosphokinase [EC:2.7.6.1]
K00948 PRPS; ribose-phosphate pyrophosphokinase [EC:2.7.6.1]
K00948 PRPS; ribose-phosphate pyrophosphokinase [EC:2.7.6.1]
K00764 purF; amidophosphoribosyltransferase [EC:2.4.2.14]
K11787 GART; phosphoribosylamine--glycine ligase / phosphoribosylglycinamide formyltransferase / phosphoribosylformylglycinamidine cyclo-ligase [EC:6.3.4.13 2.1.2.2 6.3.3.1]
K01952 PFAS; phosphoribosylformylglycinamidine synthase [EC:6.3.5.3]
K01587 PAICS; phosphoribosylaminoimidazole carboxylase / phosphoribosylaminoimidazole-succinocarboxamide synthase [EC:4.1.1.21 6.3.2.6]
K01756 purB; adenylosuccinate lyase [EC:4.3.2.2]
K00602 purH; phosphoribosylaminoimidazolecarboxamide formyltransferase / IMP cyclohydrolase [EC:2.1.2.3 3.5.4.10]
K00759 APRT; adenine phosphoribosyltransferase [EC:2.4.2.7]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K01081 E3.1.3.5; 5'-nucleotidase [EC:3.1.3.5]
K19970 NT5E; 5'-nucleotidase [EC:3.1.3.5]
K03783 punA; purine-nucleoside phosphorylase [EC:2.4.2.1]
K05810 LACC1; purine-nucleoside/S-methyl-5'-thioadenosine phosphorylase / adenosine deaminase [EC:2.4.2.1 2.4.2.28 3.5.4.4]
K00760 hprT; hypoxanthine phosphoribosyltransferase [EC:2.4.2.8]
K00088 IMPDH; IMP dehydrogenase [EC:1.1.1.205]
K00088 IMPDH; IMP dehydrogenase [EC:1.1.1.205]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K00940 ndk; nucleoside-diphosphate kinase [EC:2.7.4.6]
K18533 AK9; adenylate/nucleoside-diphosphate kinase [EC:2.7.4.3 2.7.4.6]
K01510 ENTPD1_3_8; apyrase [EC:3.6.1.5]
K01510 ENTPD1_3_8; apyrase [EC:3.6.1.5]
K01510 ENTPD1_3_8; apyrase [EC:3.6.1.5]
K12304 CANT1; soluble calcium-activated nucleotidase 1 [EC:3.6.1.6]
K12305 ENTPD4; ectonucleoside triphosphate diphosphohydrolase 4 [EC:3.6.1.6]
K01511 ENTPD5_6; ectonucleoside triphosphate diphosphohydrolase 5/6 [EC:3.6.1.6]
K01511 ENTPD5_6; ectonucleoside triphosphate diphosphohydrolase 5/6 [EC:3.6.1.6]
K16855 NUDT16; U8 snoRNA-decapping enzyme [EC:3.6.1.62 3.6.1.64]
K01519 rdgB; XTP/dITP diphosphohydrolase [EC:3.6.1.66]
K00106 XDH; xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
K01518 NUDT2; bis(5'-nucleosidyl)-tetraphosphatase [EC:3.6.1.17]
K01951 guaA; GMP synthase (glutamine-hydrolysing) [EC:6.3.5.2]
K00364 guaC; GMP reductase [EC:1.7.1.7]
K00364 guaC; GMP reductase [EC:1.7.1.7]
K01487 guaD; guanine deaminase [EC:3.5.4.3]
K00942 gmk; guanylate kinase [EC:2.7.4.8]
K10807 RRM1; ribonucleoside-diphosphate reductase subunit M1 [EC:1.17.4.1]
K10808 RRM2; ribonucleoside-diphosphate reductase subunit M2 [EC:1.17.4.1]
K10808 RRM2; ribonucleoside-diphosphate reductase subunit M2 [EC:1.17.4.1]
K07023 YGK1; 5'-deoxynucleotidase [EC:3.1.3.89]
K00904 DGUOK; deoxyguanosine kinase [EC:2.7.1.113]
K00893 DCK; deoxycitidine/deoxyadenosine/deoxyguanosine kinase [EC:2.7.1.74 2.7.1.76 2.7.1.113]
K21138 HDDC3; guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase [EC:3.1.7.2]
K01514 PRUNE; exopolyphosphatase [EC:3.6.1.11]
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K11265 ADCY10; adenylate cyclase 10 [EC:4.6.1.1]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12319 GUCY1B; guanylate cyclase soluble subunit beta [EC:4.6.1.2]
K12320 GUCY2C; heat-stable enterotoxin receptor [EC:4.6.1.2]
K12321 GUCY2D_E; guanylate cyclase 2D/E [EC:4.6.1.2]
K12322 GUCY2F; guanylate cyclase 2F [EC:4.6.1.2]
K12323 ANPRA; atrial natriuretic peptide receptor A [EC:4.6.1.2]
K12324 ANPRB; atrial natriuretic peptide receptor B [EC:4.6.1.2]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K18283 PDE2A; cGMP-dependent 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
K19021 PDE3A; cGMP-inhibited 3',5'-cyclic phosphodiesterase A [EC:3.1.4.17]
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B [EC:3.1.4.17]
K13762 PDE5; cGMP-specific 3',5'-cyclic phosphodiesterase [EC:3.1.4.35]
K08718 PDE6A; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha [EC:3.1.4.35]
K13756 PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta [EC:3.1.4.35]
K13757 PDE6C; cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' [EC:3.1.4.35]
K13758 PDE6D; retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta
K13759 PDE6G; retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
K13760 PDE6H; retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
K13761 PDE9; high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9 [EC:3.1.4.35]
K18438 PDE10; cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10 [EC:3.1.4.17 3.1.4.35]
K13298 PDE11; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 [EC:3.1.4.17 3.1.4.35]
K01939 purA; adenylosuccinate synthase [EC:6.3.4.4]
K01939 purA; adenylosuccinate synthase [EC:6.3.4.4]
K01490 AMPD; AMP deaminase [EC:3.5.4.6]
K01490 AMPD; AMP deaminase [EC:3.5.4.6]
K01490 AMPD; AMP deaminase [EC:3.5.4.6]
K00856 ADK; adenosine kinase [EC:2.7.1.20]
K01488 add; adenosine deaminase [EC:3.5.4.4]
K19572 CECR1; adenosine deaminase CECR1 [EC:3.5.4.4]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K00939 adk; adenylate kinase [EC:2.7.4.3]
K18532 AK6; adenylate kinase [EC:2.7.4.3]
K00944 AK3; nucleoside-triphosphate--adenylate kinase [EC:2.7.4.10]
K01509 ENTPD2; adenosinetriphosphatase [EC:3.6.1.-]
K06928 NTPCR; nucleoside-triphosphatase [EC:3.6.1.15]
K01513 ENPP1_3; ectonucleotide pyrophosphatase/phosphodiesterase family member 1/3 [EC:3.1.4.1 3.6.1.9]
K01513 ENPP1_3; ectonucleotide pyrophosphatase/phosphodiesterase family member 1/3 [EC:3.1.4.1 3.6.1.9]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K18436 PDE7; high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 [EC:3.1.4.53]
K18436 PDE7; high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 [EC:3.1.4.53]
K18437 PDE8; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8 [EC:3.1.4.53]
K18437 PDE8; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8 [EC:3.1.4.53]
K01522 FHIT; bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]
K18424 ENPP4; ectonucleotide pyrophosphatase/phosphodiesterase family member 4 [EC:3.6.1.29]
K13811 PAPSS; 3'-phosphoadenosine 5'-phosphosulfate synthase [EC:2.7.7.4 2.7.1.25]
K13811 PAPSS; 3'-phosphoadenosine 5'-phosphosulfate synthase [EC:2.7.7.4 2.7.1.25]
K13485 PRHOXNB; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase [EC:4.1.1.97]
K01477 alc; allantoicase [EC:3.5.3.4]
|
00240 Pyrimidine metabolism [PATH:hsa00240]
|
|
|
09105 Amino acid metabolism
|
|
|
09106 Metabolism of other amino acids
|
|
|
09107 Glycan biosynthesis and metabolism
|
|
|
09108 Metabolism of cofactors and vitamins
|
|
|
09109 Metabolism of terpenoids and polyketides
|
|
|
09110 Biosynthesis of other secondary metabolites
|
|
|
09111 Xenobiotics biodegradation and metabolism
|
|
|
09112 Not included in regular maps
|
|
|
09120 Genetic Information Processing
|
|
|
09130 Environmental Information Processing
|
|
|
09131 Membrane transport
|
|
|
09132 Signal transduction
|
02020 Two-component system
|
04010 MAPK signaling pathway [PATH:hsa04010]
|
04013 MAPK signaling pathway - fly
|
04016 MAPK signaling pathway - plant
|
04011 MAPK signaling pathway - yeast
|
04012 ErbB signaling pathway [PATH:hsa04012]
|
04014 Ras signaling pathway [PATH:hsa04014]
|
04015 Rap1 signaling pathway [PATH:hsa04015]
|
04310 Wnt signaling pathway [PATH:hsa04310]
|
04330 Notch signaling pathway [PATH:hsa04330]
|
04340 Hedgehog signaling pathway [PATH:hsa04340]
|
04341 Hedgehog signaling pathway - fly
|
04350 TGF-beta signaling pathway [PATH:hsa04350]
|
04390 Hippo signaling pathway [PATH:hsa04390]
|
04391 Hippo signaling pathway - fly
|
04392 Hippo signaling pathway - multiple species [PATH:hsa04392]
|
04370 VEGF signaling pathway [PATH:hsa04370]
|
04371 Apelin signaling pathway [PATH:hsa04371]
|
04630 JAK-STAT signaling pathway [PATH:hsa04630]
|
04064 NF-kappa B signaling pathway [PATH:hsa04064]
|
04668 TNF signaling pathway [PATH:hsa04668]
|
04066 HIF-1 signaling pathway [PATH:hsa04066]
|
04068 FoxO signaling pathway [PATH:hsa04068]
|
04020 Calcium signaling pathway [PATH:hsa04020]
|
04070 Phosphatidylinositol signaling system [PATH:hsa04070]
|
04072 Phospholipase D signaling pathway [PATH:hsa04072]
|
04071 Sphingolipid signaling pathway [PATH:hsa04071]
|
04024 cAMP signaling pathway [PATH:hsa04024]
|
7432 VIP; vasoactive intestinal peptide
1392 CRH; corticotropin releasing hormone
1081 CGA; glycoprotein hormones, alpha polypeptide
3972 LHB; luteinizing hormone subunit beta
170589 GPHA2; glycoprotein hormone subunit alpha 2
122876 GPHB5; glycoprotein hormone subunit beta 5
7252 TSHB; thyroid stimulating hormone subunit beta
5443 POMC; proopiomelanocortin
2641 GCG; glucagon
2695 GIP; gastric inhibitory polypeptide
2488 FSHB; follicle stimulating hormone subunit beta
4878 NPPA; natriuretic peptide A
116 ADCYAP1; adenylate cyclase activating polypeptide 1
153 ADRB1; adrenoceptor beta 1
154 ADRB2; adrenoceptor beta 2
1812 DRD1; dopamine receptor D1
1816 DRD5; dopamine receptor D5
135 ADORA2A; adenosine A2a receptor
3360 HTR4; 5-hydroxytryptamine receptor 4
3362 HTR6; 5-hydroxytryptamine receptor 6
5732 PTGER2; prostaglandin E receptor 2
117 ADCYAP1R1; ADCYAP receptor type I
7434 VIPR2; vasoactive intestinal peptide receptor 2
1394 CRHR1; corticotropin releasing hormone receptor 1
1395 CRHR2; corticotropin releasing hormone receptor 2
3973 LHCGR; luteinizing hormone/choriogonadotropin receptor
7253 TSHR; thyroid stimulating hormone receptor
4158 MC2R; melanocortin 2 receptor
2740 GLP1R; glucagon like peptide 1 receptor
2696 GIPR; gastric inhibitory polypeptide receptor
139760 GPR119; G protein-coupled receptor 119
2492 FSHR; follicle stimulating hormone receptor
4881 NPR1; natriuretic peptide receptor 1
2778 GNAS; GNAS complex locus
1906 EDN1; endothelin 1
1907 EDN2; endothelin 2
1908 EDN3; endothelin 3
6750 SST; somatostatin
4852 NPY; neuropeptide Y
51738 GHRL; ghrelin and obestatin prepropeptide
5020 OXT; oxytocin/neurophysin I prepropeptide
3350 HTR1A; 5-hydroxytryptamine receptor 1A
3351 HTR1B; 5-hydroxytryptamine receptor 1B
3352 HTR1D; 5-hydroxytryptamine receptor 1D
3354 HTR1E; 5-hydroxytryptamine receptor 1E
3355 HTR1F; 5-hydroxytryptamine receptor 1F
1128 CHRM1; cholinergic receptor muscarinic 1
1129 CHRM2; cholinergic receptor muscarinic 2
1813 DRD2; dopamine receptor D2
2550 GABBR1; gamma-aminobutyric acid type B receptor subunit 1
9568 GABBR2; gamma-aminobutyric acid type B receptor subunit 2
134 ADORA1; adenosine A1 receptor
1909 EDNRA; endothelin receptor type A
4886 NPY1R; neuropeptide Y receptor Y1
6751 SSTR1; somatostatin receptor 1
6752 SSTR2; somatostatin receptor 2
6755 SSTR5; somatostatin receptor 5
27198 HCAR1; hydroxycarboxylic acid receptor 1
338442 HCAR2; hydroxycarboxylic acid receptor 2
8843 HCAR3; hydroxycarboxylic acid receptor 3
2867 FFAR2; free fatty acid receptor 2
56670 SUCNR1; succinate receptor 1
5733 PTGER3; prostaglandin E receptor 3
5021 OXTR; oxytocin receptor
2693 GHSR; growth hormone secretagogue receptor
2770 GNAI1; G protein subunit alpha i1
2773 GNAI3; G protein subunit alpha i3
2771 GNAI2; G protein subunit alpha i2
107 ADCY1; adenylate cyclase 1
108 ADCY2; adenylate cyclase 2
109 ADCY3; adenylate cyclase 3
196883 ADCY4; adenylate cyclase 4
111 ADCY5; adenylate cyclase 5
112 ADCY6; adenylate cyclase 6
113 ADCY7; adenylate cyclase 7
114 ADCY8; adenylate cyclase 8
115 ADCY9; adenylate cyclase 9
55811 ADCY10; adenylate cyclase 10
1259 CNGA1; cyclic nucleotide gated channel subunit alpha 1
1260 CNGA2; cyclic nucleotide gated channel subunit alpha 2
1261 CNGA3; cyclic nucleotide gated channel subunit alpha 3
1262 CNGA4; cyclic nucleotide gated channel subunit alpha 4
1258 CNGB1; cyclic nucleotide gated channel subunit beta 1
54714 CNGB3; cyclic nucleotide gated channel subunit beta 3
810 CALML3; calmodulin like 3
805 CALM2; calmodulin 2
808 CALM3; calmodulin 3
801 CALM1; calmodulin 1
163688 CALML6; calmodulin like 6
51806 CALML5; calmodulin like 5
91860 CALML4; calmodulin like 4
815 CAMK2A; calcium/calmodulin dependent protein kinase II alpha
817 CAMK2D; calcium/calmodulin dependent protein kinase II delta
816 CAMK2B; calcium/calmodulin dependent protein kinase II beta
818 CAMK2G; calcium/calmodulin dependent protein kinase II gamma
814 CAMK4; calcium/calmodulin dependent protein kinase IV
11149 BVES; blood vessel epicardial substance
64091 POPDC2; popeye domain containing 2
64208 POPDC3; popeye domain containing 3
3776 KCNK2; potassium two pore domain channel subfamily K member 2
610 HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
10021 HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel 4
10257 ABCC4; ATP binding cassette subfamily C member 4 (PEL blood group)
10411 RAPGEF3; Rap guanine nucleotide exchange factor 3
11069 RAPGEF4; Rap guanine nucleotide exchange factor 4
6237 RRAS; RAS related
22800 RRAS2; RAS related 2
5337 PLD1; phospholipase D1
5338 PLD2; phospholipase D2
51196 PLCE1; phospholipase C epsilon 1
5599 MAPK8; mitogen-activated protein kinase 8
5602 MAPK10; mitogen-activated protein kinase 10
5601 MAPK9; mitogen-activated protein kinase 9
5906 RAP1A; RAP1A, member of RAS oncogene family
5908 RAP1B; RAP1B, member of RAS oncogene family
7074 TIAM1; TIAM Rac1 associated GEF 1
10451 VAV3; vav guanine nucleotide exchange factor 3
7409 VAV1; vav guanine nucleotide exchange factor 1
7410 VAV2; vav guanine nucleotide exchange factor 2
5879 RAC1; Rac family small GTPase 1
5880 RAC2; Rac family small GTPase 2
5881 RAC3; Rac family small GTPase 3
5058 PAK1; p21 (RAC1) activated kinase 1
64411 ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
387 RHOA; ras homolog family member A
4301 AFDN; afadin, adherens junction formation factor
5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
5295 PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
5296 PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
8503 PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
207 AKT1; AKT serine/threonine kinase 1
208 AKT2; AKT serine/threonine kinase 2
10000 AKT3; AKT serine/threonine kinase 3
673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
5604 MAP2K1; mitogen-activated protein kinase kinase 1
5605 MAP2K2; mitogen-activated protein kinase kinase 2
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
5566 PRKACA; protein kinase cAMP-activated catalytic subunit alpha
5567 PRKACB; protein kinase cAMP-activated catalytic subunit beta
5568 PRKACG; protein kinase cAMP-activated catalytic subunit gamma
84152 PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B
5499 PPP1CA; protein phosphatase 1 catalytic subunit alpha
5500 PPP1CB; protein phosphatase 1 catalytic subunit beta
5501 PPP1CC; protein phosphatase 1 catalytic subunit gamma
1385 CREB1; cAMP responsive element binding protein 1
10488 CREB3; cAMP responsive element binding protein 3
90993 CREB3L1; cAMP responsive element binding protein 3 like 1
64764 CREB3L2; cAMP responsive element binding protein 3 like 2
84699 CREB3L3; cAMP responsive element binding protein 3 like 3
148327 CREB3L4; cAMP responsive element binding protein 3 like 4
9586 CREB5; cAMP responsive element binding protein 5
1387 CREBBP; CREB binding protein
2033 EP300; E1A binding protein p300
627 BDNF; brain derived neurotrophic factor
2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit
3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit
2737 GLI3; GLI family zinc finger 3
2735 GLI1; GLI family zinc finger 1
5727 PTCH1; patched 1
64399 HHIP; hedgehog interacting protein
4792 NFKBIA; NFKB inhibitor alpha
4790 NFKB1; nuclear factor kappa B subunit 1
5970 RELA; RELA proto-oncogene, NF-kB subunit
6662 SOX9; SRY-box transcription factor 9
268 AMH; anti-Mullerian hormone
5465 PPARA; peroxisome proliferator activated receptor alpha
8310 ACOX3; acyl-CoA oxidase 3, pristanoyl
51 ACOX1; acyl-CoA oxidase 1
4772 NFATC1; nuclear factor of activated T cells 1
2149 F2R; coagulation factor II thrombin receptor
572 BAD; BCL2 associated agonist of cell death
3991 LIPE; lipase E, hormone sensitive type
6093 ROCK1; Rho associated coiled-coil containing protein kinase 1
9475 ROCK2; Rho associated coiled-coil containing protein kinase 2
4659 PPP1R12A; protein phosphatase 1 regulatory subunit 12A
10398 MYL9; myosin light chain 9
7137 TNNI3; troponin I3, cardiac type
5350 PLN; phospholamban
487 ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
489 ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
488 ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
6262 RYR2; ryanodine receptor 2
2902 GRIN1; glutamate ionotropic receptor NMDA type subunit 1
2903 GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A
2904 GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B
2905 GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C
2906 GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D
116443 GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A
116444 GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B
2890 GRIA1; glutamate ionotropic receptor AMPA type subunit 1
2891 GRIA2; glutamate ionotropic receptor AMPA type subunit 2
2892 GRIA3; glutamate ionotropic receptor AMPA type subunit 3
2893 GRIA4; glutamate ionotropic receptor AMPA type subunit 4
1080 CFTR; CF transmembrane conductance regulator
476 ATP1A1; ATPase Na+/K+ transporting subunit alpha 1
477 ATP1A2; ATPase Na+/K+ transporting subunit alpha 2
478 ATP1A3; ATPase Na+/K+ transporting subunit alpha 3
480 ATP1A4; ATPase Na+/K+ transporting subunit alpha 4
23439 ATP1B4; ATPase Na+/K+ transporting family member beta 4
481 ATP1B1; ATPase Na+/K+ transporting subunit beta 1
482 ATP1B2; ATPase Na+/K+ transporting subunit beta 2
483 ATP1B3; ATPase Na+/K+ transporting subunit beta 3
486 FXYD2; FXYD domain containing ion transport regulator 2
5348 FXYD1; FXYD domain containing ion transport regulator 1
6548 SLC9A1; solute carrier family 9 member A1
84876 ORAI1; ORAI calcium release-activated calcium modulator 1
490 ATP2B1; ATPase plasma membrane Ca2+ transporting 1
492 ATP2B3; ATPase plasma membrane Ca2+ transporting 3
493 ATP2B4; ATPase plasma membrane Ca2+ transporting 4
491 ATP2B2; ATPase plasma membrane Ca2+ transporting 2
775 CACNA1C; calcium voltage-gated channel subunit alpha1 C
776 CACNA1D; calcium voltage-gated channel subunit alpha1 D
778 CACNA1F; calcium voltage-gated channel subunit alpha1 F
779 CACNA1S; calcium voltage-gated channel subunit alpha1 S
5139 PDE3A; phosphodiesterase 3A
5140 PDE3B; phosphodiesterase 3B
5141 PDE4A; phosphodiesterase 4A
5142 PDE4B; phosphodiesterase 4B
5143 PDE4C; phosphodiesterase 4C
5144 PDE4D; phosphodiesterase 4D
10846 PDE10A; phosphodiesterase 10A
|
K05264 VIP; vasoactive intestinal peptide
K05256 CRH; corticotropin-releasing hormone
K08522 CGA; glycoprotein hormones alpha chain
K08521 LHB; lutropin subunit beta
K25483 GPHA2; glycoprotein hormone alpha-2
K25484 GPHB5; glycoprotein hormone beta-5
K05251 TSHB; thyrotropin subunit beta
K05228 POMC; proopiomelanocortin
K05259 GCG; glucagon
K05258 GIP; gastric inhibitory polypeptide
K05250 FSHB; follitropin subunit beta
K12334 NPPA; natriuretic peptide A
K05262 ADCYAP; pituitary adenylate cyclase-activating polypeptide
K04141 ADRB1; adrenergic receptor beta-1
K04142 ADRB2; adrenergic receptor beta-2
K04144 DRD1; dopamine receptor D1
K05840 DRD5; dopamine receptor D5
K04266 ADORA2A; adenosine receptor A2a
K04160 HTR4; 5-hydroxytryptamine receptor 4
K04162 HTR6; 5-hydroxytryptamine receptor 6
K04259 PTGER2; prostaglandin E receptor 2
K04587 ADCYAP1R1; pituitary adenylate cyclase-activating polypeptide type I receptor
K04590 VIPR2; vasoactive intestinal peptide receptor 2
K04578 CRHR1; corticotropin releasing hormone receptor 1
K04579 CRHR2; corticotropin releasing hormone receptor 2
K04248 LHCGR; lutropin-choriogonadotropic hormone receptor
K04249 TSHR; thyrotropin receptor
K04200 MC2R; melanocortin 2 receptor
K04581 GLP1R; glucagon-like peptide 1 receptor
K04580 GIPR; gastric inhibitory polypeptide receptor
K08424 GPR119; glucose-dependent insulinotropic receptor
K04247 FSHR; follicle stimulating hormone receptor
K12323 ANPRA; atrial natriuretic peptide receptor A [EC:4.6.1.2]
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K16366 EDN1; endothelin-1
K16367 EDN2; endothelin-2
K05227 EDN3; endothelin-3
K05237 SST; somatostatin
K05232 NPY; neuropeptide Y
K05254 GHRL; ghrelin
K05243 OXT; oxytocin-neurophysin 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04129 CHRM1; muscarinic acetylcholine receptor M1
K04130 CHRM2; muscarinic acetylcholine receptor M2
K04145 DRD2; dopamine receptor D2
K04615 GABBR; gamma-aminobutyric acid type B receptor
K04615 GABBR; gamma-aminobutyric acid type B receptor
K04265 ADORA1; adenosine receptor A1
K04197 EDNRA; endothelin receptor type A
K04204 NPY1R; neuropeptide Y receptor type 1
K04217 SSTR1; somatostatin receptor 1
K04218 SSTR2; somatostatin receptor 2
K04221 SSTR5; somatostatin receptor 5
K08401 HCAR1; hydroxycarboxylic acid receptor 1
K08402 HCAR2_3; hydroxycarboxylic acid receptor 2/3
K08402 HCAR2_3; hydroxycarboxylic acid receptor 2/3
K04328 FFAR2; free fatty acid receptor 2
K10042 SUCNR1; succinate receptor 1
K04260 PTGER3; prostaglandin E receptor 3
K04229 OXTR; oxytocin receptor
K04284 GHSR; growth hormone secretagogue receptor
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K11265 ADCY10; adenylate cyclase 10 [EC:4.6.1.1]
K04948 CNGA1; cyclic nucleotide gated channel alpha 1
K04949 CNGA2; cyclic nucleotide gated channel alpha 2
K04950 CNGA3; cyclic nucleotide gated channel alpha 3
K04951 CNGA4; cyclic nucleotide gated channel alpha 4
K04952 CNGB1; cyclic nucleotide gated channel beta 1
K04953 CNGB3; cyclic nucleotide gated channel beta 3
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K05869 CAMK4; calcium/calmodulin-dependent protein kinase IV [EC:2.7.11.17]
K21108 BVES; blood vessel epicardial substance
K26206 POPDC2; popeye domain-containing protein 2
K26207 POPDC3; popeye domain-containing protein 3
K04913 KCNK2; potassium channel subfamily K member 2
K04955 HCN2; hyperpolarization activated cyclic nucleotide-gated potassium channel 2
K04957 HCN4; hyperpolarization activated cyclic nucleotide-gated potassium channel 4
K05673 ABCC4; ATP-binding cassette, subfamily C (CFTR/MRP), member 4
K08014 RAPGEF3; Rap guanine nucleotide exchange factor 3
K04351 RAPGEF4; Rap guanine nucleotide exchange factor 4
K07829 RRAS; Ras-related protein R-Ras
K07830 RRAS2; Ras-related protein R-Ras2
K01115 PLD1_2; phospholipase D1/2 [EC:3.1.4.4]
K01115 PLD1_2; phospholipase D1/2 [EC:3.1.4.4]
K05860 PLCE; phosphatidylinositol phospholipase C, epsilon [EC:3.1.4.11]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04353 RAP1A; Ras-related protein Rap-1A
K07836 RAP1B; Ras-related protein Rap-1B
K05731 TIAM1; T-lymphoma invasion and metastasis-inducing protein 1
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K12490 ARAP3; Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3
K04513 RHOA; Ras homolog gene family, member A
K05702 AF6; afadin
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K15494 PPP1R1B; protein phosphatase 1 regulatory subunit 1B
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09047 CREB5; cyclic AMP-responsive element-binding protein 5
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04355 BDNF; brain-derived neurotrophic factor
K04379 FOS; proto-oncogene protein c-fos
K04448 JUN; transcription factor AP-1
K06230 GLI3; zinc finger protein GLI3
K16797 GLI1; zinc finger protein GLI1
K06225 PTCH1; patched 1
K06231 HHIP; hedgehog interacting protein
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K18435 SOX9; transcription factor SOX9 (SOX group E)
K04665 AMH; anti-mullerian hormone
K07294 NR1C1; peroxisome proliferator-activated receptor alpha
K00232 E1.3.3.6; acyl-CoA oxidase [EC:1.3.3.6]
K00232 E1.3.3.6; acyl-CoA oxidase [EC:1.3.3.6]
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K03914 F2R; coagulation factor II (thrombin) receptor
K02158 BAD; Bcl-2-antagonist of cell death
K07188 LIPE; hormone-sensitive lipase [EC:3.1.1.79]
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K17388 ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.1]
K06270 PPP1R12A; protein phosphatase 1 regulatory subunit 12A
K12755 MYL9; myosin regulatory light chain 9
K12044 TNNI3; troponin I, cardiac muscle
K05852 PLN; phospholamban
K05853 ATP2A; P-type Ca2+ transporter type 2A [EC:7.2.2.10]
K05853 ATP2A; P-type Ca2+ transporter type 2A [EC:7.2.2.10]
K05853 ATP2A; P-type Ca2+ transporter type 2A [EC:7.2.2.10]
K04962 RYR2; ryanodine receptor 2
K05208 GRIN1; glutamate receptor ionotropic, NMDA 1
K05209 GRIN2A; glutamate receptor ionotropic, NMDA 2A
K05210 GRIN2B; glutamate receptor ionotropic, NMDA 2B
K05211 GRIN2C; glutamate receptor ionotropic, NMDA 2C
K05212 GRIN2D; glutamate receptor ionotropic, NMDA 2D
K05213 GRIN3A; glutamate receptor ionotropic, NMDA 3A
K05214 GRIN3B; glutamate receptor ionotropic, NMDA 3B
K05197 GRIA1; glutamate receptor 1
K05198 GRIA2; glutamate receptor 2
K05199 GRIA3; glutamate receptor 3
K05200 GRIA4; glutamate receptor 4
K05031 CFTR; cystic fibrosis transmembrane conductance regulator [EC:5.6.1.6]
K01539 ATP1A; sodium/potassium-transporting ATPase subunit alpha [EC:7.2.2.13]
K01539 ATP1A; sodium/potassium-transporting ATPase subunit alpha [EC:7.2.2.13]
K01539 ATP1A; sodium/potassium-transporting ATPase subunit alpha [EC:7.2.2.13]
K01539 ATP1A; sodium/potassium-transporting ATPase subunit alpha [EC:7.2.2.13]
K01540 ATP1B; sodium/potassium-transporting ATPase subunit beta
K01540 ATP1B; sodium/potassium-transporting ATPase subunit beta
K01540 ATP1B; sodium/potassium-transporting ATPase subunit beta
K01540 ATP1B; sodium/potassium-transporting ATPase subunit beta
K01538 FXYD2; sodium/potassium-transporting ATPase subunit gamma (FXYD domain-containing ion transport regulator 2)
K13360 FXYD1; FXYD domain-containing ion transport regulator 1
K05742 SLC9A1; solute carrier family 9 (sodium/hydrogen exchanger), member 1
K16056 ORAI1; calcium release-activated calcium channel protein 1
K05850 ATP2B; P-type Ca2+ transporter type 2B [EC:7.2.2.10]
K05850 ATP2B; P-type Ca2+ transporter type 2B [EC:7.2.2.10]
K05850 ATP2B; P-type Ca2+ transporter type 2B [EC:7.2.2.10]
K05850 ATP2B; P-type Ca2+ transporter type 2B [EC:7.2.2.10]
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K19021 PDE3A; cGMP-inhibited 3',5'-cyclic phosphodiesterase A [EC:3.1.4.17]
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B [EC:3.1.4.17]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K18438 PDE10; cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10 [EC:3.1.4.17 3.1.4.35]
|
04022 cGMP-PKG signaling pathway [PATH:hsa04022]
|
04151 PI3K-Akt signaling pathway [PATH:hsa04151]
|
04152 AMPK signaling pathway [PATH:hsa04152]
|
04150 mTOR signaling pathway [PATH:hsa04150]
|
04075 Plant hormone signal transduction
|
|
|
09133 Signaling molecules and interaction
|
|
|
09140 Cellular Processes
|
|
|
09150 Organismal Systems
|
|
|
09151 Immune system
|
|
|
09152 Endocrine system
|
04911 Insulin secretion [PATH:hsa04911]
|
04910 Insulin signaling pathway [PATH:hsa04910]
|
04922 Glucagon signaling pathway [PATH:hsa04922]
|
04923 Regulation of lipolysis in adipocytes [PATH:hsa04923]
|
04920 Adipocytokine signaling pathway [PATH:hsa04920]
|
03320 PPAR signaling pathway [PATH:hsa03320]
|
04929 GnRH secretion [PATH:hsa04929]
|
04912 GnRH signaling pathway [PATH:hsa04912]
|
04913 Ovarian steroidogenesis [PATH:hsa04913]
|
04915 Estrogen signaling pathway [PATH:hsa04915]
|
04914 Progesterone-mediated oocyte maturation [PATH:hsa04914]
|
04917 Prolactin signaling pathway [PATH:hsa04917]
|
04921 Oxytocin signaling pathway [PATH:hsa04921]
|
04926 Relaxin signaling pathway [PATH:hsa04926]
|
04935 Growth hormone synthesis, secretion and action [PATH:hsa04935]
|
04918 Thyroid hormone synthesis [PATH:hsa04918]
|
04919 Thyroid hormone signaling pathway [PATH:hsa04919]
|
04928 Parathyroid hormone synthesis, secretion and action [PATH:hsa04928]
|
846 CASR; calcium sensing receptor
2770 GNAI1; G protein subunit alpha i1
2773 GNAI3; G protein subunit alpha i3
2771 GNAI2; G protein subunit alpha i2
107 ADCY1; adenylate cyclase 1
108 ADCY2; adenylate cyclase 2
109 ADCY3; adenylate cyclase 3
196883 ADCY4; adenylate cyclase 4
111 ADCY5; adenylate cyclase 5
112 ADCY6; adenylate cyclase 6
113 ADCY7; adenylate cyclase 7
114 ADCY8; adenylate cyclase 8
115 ADCY9; adenylate cyclase 9
2776 GNAQ; G protein subunit alpha q
2767 GNA11; G protein subunit alpha 11
23236 PLCB1; phospholipase C beta 1
5330 PLCB2; phospholipase C beta 2
5331 PLCB3; phospholipase C beta 3
5332 PLCB4; phospholipase C beta 4
3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2
3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3
8521 GCM1; glial cells missing transcription factor 1
9247 GCM2; glial cells missing transcription factor 2
9935 MAFB; MAF bZIP transcription factor B
2625 GATA3; GATA binding protein 3
6667 SP1; Sp1 transcription factor
7421 VDR; vitamin D receptor
6256 RXRA; retinoid X receptor alpha
6257 RXRB; retinoid X receptor beta
6258 RXRG; retinoid X receptor gamma
8074 FGF23; fibroblast growth factor 23
2260 FGFR1; fibroblast growth factor receptor 1
9365 KL; klotho
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
1958 EGR1; early growth response 1
5741 PTH; parathyroid hormone
6446 SGK1; serum/glucocorticoid regulated kinase 1
65125 WNK1; WNK lysine deficient protein kinase 1
65266 WNK4; WNK lysine deficient protein kinase 4
65267 WNK3; WNK lysine deficient protein kinase 3
65268 WNK2; WNK lysine deficient protein kinase 2
9943 OXSR1; oxidative stress responsive kinase 1
27347 STK39; serine/threonine kinase 39
6559 SLC12A3; solute carrier family 12 member 3
5744 PTHLH; parathyroid hormone like hormone
5745 PTH1R; parathyroid hormone 1 receptor
5578 PRKCA; protein kinase C alpha
5579 PRKCB; protein kinase C beta
5582 PRKCG; protein kinase C gamma
56302 TRPV5; transient receptor potential cation channel subfamily V member 5
6569 SLC34A1; solute carrier family 34 member 1
10568 SLC34A2; solute carrier family 34 member 2
142680 SLC34A3; solute carrier family 34 member 3
9368 NHERF1; NHERF family PDZ scaffold protein 1
2778 GNAS; GNAS complex locus
5141 PDE4A; phosphodiesterase 4A
5142 PDE4B; phosphodiesterase 4B
5143 PDE4C; phosphodiesterase 4C
5144 PDE4D; phosphodiesterase 4D
5566 PRKACA; protein kinase cAMP-activated catalytic subunit alpha
5567 PRKACB; protein kinase cAMP-activated catalytic subunit beta
5568 PRKACG; protein kinase cAMP-activated catalytic subunit gamma
1594 CYP27B1; cytochrome P450 family 27 subfamily B member 1
1591 CYP24A1; cytochrome P450 family 24 subfamily A member 1
4205 MEF2A; myocyte enhancer factor 2A
4208 MEF2C; myocyte enhancer factor 2C
4209 MEF2D; myocyte enhancer factor 2D
50964 SOST; sclerostin
4929 NR4A2; nuclear receptor subfamily 4 group A member 2
4666 NACA; nascent polypeptide associated complex subunit alpha
3727 JUND; JunD proto-oncogene, AP-1 transcription factor subunit
632 BGLAP; bone gamma-carboxyglutamate protein
4041 LRP5; LDL receptor related protein 5
4040 LRP6; LDL receptor related protein 6
1385 CREB1; cAMP responsive element binding protein 1
1386 ATF2; activating transcription factor 2
10488 CREB3; cAMP responsive element binding protein 3
90993 CREB3L1; cAMP responsive element binding protein 3 like 1
64764 CREB3L2; cAMP responsive element binding protein 3 like 2
84699 CREB3L3; cAMP responsive element binding protein 3 like 3
148327 CREB3L4; cAMP responsive element binding protein 3 like 4
468 ATF4; activating transcription factor 4
9586 CREB5; cAMP responsive element binding protein 5
1388 ATF6B; activating transcription factor 6 beta
8600 TNFSF11; TNF superfamily member 11
596 BCL2; BCL2 apoptosis regulator
1026 CDKN1A; cyclin dependent kinase inhibitor 1A
2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit
860 RUNX2; RUNX family transcription factor 2
4322 MMP13; matrix metallopeptidase 13
2768 GNA12; G protein subunit alpha 12
10672 GNA13; G protein subunit alpha 13
9138 ARHGEF1; Rho guanine nucleotide exchange factor 1
9826 ARHGEF11; Rho guanine nucleotide exchange factor 11
11214 AKAP13; A-kinase anchoring protein 13
387 RHOA; ras homolog family member A
5337 PLD1; phospholipase D1
5338 PLD2; phospholipase D2
408 ARRB1; arrestin beta 1
409 ARRB2; arrestin beta 2
369 ARAF; A-Raf proto-oncogene, serine/threonine kinase
673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
5604 MAP2K1; mitogen-activated protein kinase kinase 1
4323 MMP14; matrix metallopeptidase 14
4324 MMP15; matrix metallopeptidase 15
4325 MMP16; matrix metallopeptidase 16
4326 MMP17; matrix metallopeptidase 17
10893 MMP24; matrix metallopeptidase 24
64386 MMP25; matrix metallopeptidase 25
1839 HBEGF; heparin binding EGF like growth factor
1956 EGFR; epidermal growth factor receptor
|
K04612 CASR; calcium-sensing receptor
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K04635 GNA11; guanine nucleotide-binding protein subunit alpha-11
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K21598 GCM; chorion-specific transcription factor GCM
K21598 GCM; chorion-specific transcription factor GCM
K09036 MAFB; transcription factor MAFB
K17895 GATA3; GATA-binding protein 3
K04684 SP1; transcription factor Sp1
K08539 VDR; vitamin D3 receptor
K08524 RXRA; retinoid X receptor alpha
K08525 RXRB; retinoid X receptor beta
K08526 RXRG; retinoid X receptor gamma
K22428 FGF23; fibroblast growth factor 23
K04362 FGFR1; fibroblast growth factor receptor 1 [EC:2.7.10.1]
K14756 KL; klotho [EC:3.2.1.31]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K09203 EGR1; early growth response protein 1
K05261 PTH; parathyroid hormone
K13302 SGK1; serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1]
K08867 WNK; WNK lysine deficient protein kinase [EC:2.7.11.1]
K08867 WNK; WNK lysine deficient protein kinase [EC:2.7.11.1]
K08867 WNK; WNK lysine deficient protein kinase [EC:2.7.11.1]
K08867 WNK; WNK lysine deficient protein kinase [EC:2.7.11.1]
K08835 OXSR1; serine/threonine-protein kinase OSR1/STK39 [EC:2.7.11.1]
K08835 OXSR1; serine/threonine-protein kinase OSR1/STK39 [EC:2.7.11.1]
K14426 SLC12A3; solute carrier family 12 (sodium/chloride transporter), member 3
K22608 PTHLH; parathyroid hormone-related hormone
K04585 PTH1R; parathyroid hormone receptor 1
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K19663 PRKCG; classical protein kinase C gamma type [EC:2.7.11.13]
K04974 TRPV5; transient receptor potential cation channel subfamily V member 5
K14683 SLC34A; solute carrier family 34 (sodium-dependent phosphate cotransporter)
K14683 SLC34A; solute carrier family 34 (sodium-dependent phosphate cotransporter)
K14683 SLC34A; solute carrier family 34 (sodium-dependent phosphate cotransporter)
K13365 SLC9A3R1; sodium/hydrogen exchange regulatory cofactor NHE-RF1
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K07438 CYP27B1; calcidiol 1-monooxygenase (25-hydroxyvitamin D3 1alpha-hydroxylase) [EC:1.14.15.18]
K07436 CYP24A1; vitamin D3 24-hydroxylase [EC:1.14.15.16]
K09260 MEF2A; MADS-box transcription enhancer factor 2A
K04454 MEF2C; MADS-box transcription enhancer factor 2C
K09262 MEF2D; MADS-box transcription enhancer factor 2D
K16834 SOST; sclerostin
K08558 NR4A2; nuclear receptor subfamily 4 group A member 2
K03626 EGD2; nascent polypeptide-associated complex subunit alpha
K04449 JUND; transcription factor jun-D
K22609 BGLAP; osteocalcin
K03068 LRP5_6; low density lipoprotein receptor-related protein 5/6
K03068 LRP5_6; low density lipoprotein receptor-related protein 5/6
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K09047 CREB5; cyclic AMP-responsive element-binding protein 5
K09049 ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K02161 BCL2; apoptosis regulator Bcl-2
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K04379 FOS; proto-oncogene protein c-fos
K09278 RUNX2; runt-related transcription factor 2
K07994 MMP13; matrix metalloproteinase-13 (collagenase 3) [EC:3.4.24.-]
K04346 GNA12; guanine nucleotide-binding protein subunit alpha-12
K04639 GNA13; guanine nucleotide-binding protein subunit alpha-13
K12330 ARHGEF1; Rho guanine nucleotide exchange factor 1
K12331 ARHGEF11; Rho guanine nucleotide exchange factor 11
K16529 ARHGEF13; A-kinase anchor protein 13
K04513 RHOA; Ras homolog gene family, member A
K01115 PLD1_2; phospholipase D1/2 [EC:3.1.4.4]
K01115 PLD1_2; phospholipase D1/2 [EC:3.1.4.4]
K04439 ARRB; beta-arrestin
K04439 ARRB; beta-arrestin
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K07763 MMP14; matrix metalloproteinase-14 (membrane-inserted) [EC:3.4.24.80]
K07995 MMP15; matrix metalloproteinase-15 (membrane-inserted) [EC:3.4.24.-]
K07996 MMP16; matrix metalloproteinase-16 (membrane-inserted) [EC:3.4.24.-]
K07997 MMP17; matrix metalloproteinase-17 (membrane-inserted) [EC:3.4.24.-]
K08002 MMP24; matrix metalloproteinase-24 (membrane-inserted) [EC:3.4.24.-]
K08003 MMP25; matrix metalloproteinase-25 (membrane-inserted) [EC:3.4.24.-]
K08523 HBEGF; heparin-binding EGF-like growth factor
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
|
04916 Melanogenesis [PATH:hsa04916]
|
04924 Renin secretion [PATH:hsa04924]
|
04614 Renin-angiotensin system [PATH:hsa04614]
|
04925 Aldosterone synthesis and secretion [PATH:hsa04925]
|
04927 Cortisol synthesis and secretion [PATH:hsa04927]
|
|
|
09153 Circulatory system
|
|
|
09154 Digestive system
|
|
|
09155 Excretory system
|
|
|
09156 Nervous system
|
|
|
09157 Sensory system
|
|
|
09158 Development and regeneration
|
|
|
09149 Aging
|
|
|
09159 Environmental adaptation
|
|
|
09160 Human Diseases
|
|
|
09161 Cancer: overview
|
|
|
09162 Cancer: specific types
|
|
|
09172 Infectious disease: viral
|
|
|
09171 Infectious disease: bacterial
|
|
|
09174 Infectious disease: parasitic
|
|
|
09163 Immune disease
|
|
|
09164 Neurodegenerative disease
|
|
|
09165 Substance dependence
|
05030 Cocaine addiction [PATH:hsa05030]
|
05031 Amphetamine addiction [PATH:hsa05031]
|
05032 Morphine addiction [PATH:hsa05032]
|
4988 OPRM1; opioid receptor mu 1
1812 DRD1; dopamine receptor D1
107 ADCY1; adenylate cyclase 1
108 ADCY2; adenylate cyclase 2
109 ADCY3; adenylate cyclase 3
196883 ADCY4; adenylate cyclase 4
111 ADCY5; adenylate cyclase 5
112 ADCY6; adenylate cyclase 6
113 ADCY7; adenylate cyclase 7
114 ADCY8; adenylate cyclase 8
115 ADCY9; adenylate cyclase 9
140679 SLC32A1; solute carrier family 32 member 1
3760 KCNJ3; potassium inwardly rectifying channel subfamily J member 3
3763 KCNJ6; potassium inwardly rectifying channel subfamily J member 6
3765 KCNJ9; potassium inwardly rectifying channel subfamily J member 9
3762 KCNJ5; potassium inwardly rectifying channel subfamily J member 5
773 CACNA1A; calcium voltage-gated channel subunit alpha1 A
774 CACNA1B; calcium voltage-gated channel subunit alpha1 B
2554 GABRA1; gamma-aminobutyric acid type A receptor subunit alpha1
2555 GABRA2; gamma-aminobutyric acid type A receptor subunit alpha2
2556 GABRA3; gamma-aminobutyric acid type A receptor subunit alpha3
2557 GABRA4; gamma-aminobutyric acid type A receptor subunit alpha4
2558 GABRA5; gamma-aminobutyric acid type A receptor subunit alpha5
2559 GABRA6; gamma-aminobutyric acid type A receptor subunit alpha6
2560 GABRB1; gamma-aminobutyric acid type A receptor subunit beta1
2562 GABRB3; gamma-aminobutyric acid type A receptor subunit beta3
2561 GABRB2; gamma-aminobutyric acid type A receptor subunit beta2
2565 GABRG1; gamma-aminobutyric acid type A receptor subunit gamma1
2566 GABRG2; gamma-aminobutyric acid type A receptor subunit gamma2
2567 GABRG3; gamma-aminobutyric acid type A receptor subunit gamma3
2563 GABRD; gamma-aminobutyric acid type A receptor subunit delta
2564 GABRE; gamma-aminobutyric acid type A receptor subunit epsilon
55879 GABRQ; gamma-aminobutyric acid type A receptor subunit theta
2568 GABRP; gamma-aminobutyric acid type A receptor subunit pi
2569 GABRR1; gamma-aminobutyric acid type A receptor subunit rho1
2570 GABRR2; gamma-aminobutyric acid type A receptor subunit rho2
200959 GABRR3; gamma-aminobutyric acid type A receptor subunit rho3
2550 GABBR1; gamma-aminobutyric acid type B receptor subunit 1
9568 GABBR2; gamma-aminobutyric acid type B receptor subunit 2
2770 GNAI1; G protein subunit alpha i1
2773 GNAI3; G protein subunit alpha i3
2771 GNAI2; G protein subunit alpha i2
2775 GNAO1; G protein subunit alpha o1
2782 GNB1; G protein subunit beta 1
2783 GNB2; G protein subunit beta 2
2784 GNB3; G protein subunit beta 3
59345 GNB4; G protein subunit beta 4
10681 GNB5; G protein subunit beta 5
54331 GNG2; G protein subunit gamma 2
2785 GNG3; G protein subunit gamma 3
2786 GNG4; G protein subunit gamma 4
2787 GNG5; G protein subunit gamma 5
2788 GNG7; G protein subunit gamma 7
94235 GNG8; G protein subunit gamma 8
2790 GNG10; G protein subunit gamma 10
2791 GNG11; G protein subunit gamma 11
55970 GNG12; G protein subunit gamma 12
51764 GNG13; G protein subunit gamma 13
2792 GNGT1; G protein subunit gamma transducin 1
2793 GNGT2; G protein subunit gamma transducin 2
2778 GNAS; GNAS complex locus
156 GRK2; G protein-coupled receptor kinase 2
157 GRK3; G protein-coupled receptor kinase 3
2868 GRK4; G protein-coupled receptor kinase 4
2869 GRK5; G protein-coupled receptor kinase 5
2870 GRK6; G protein-coupled receptor kinase 6
408 ARRB1; arrestin beta 1
409 ARRB2; arrestin beta 2
5578 PRKCA; protein kinase C alpha
5579 PRKCB; protein kinase C beta
5582 PRKCG; protein kinase C gamma
5566 PRKACA; protein kinase cAMP-activated catalytic subunit alpha
5567 PRKACB; protein kinase cAMP-activated catalytic subunit beta
5568 PRKACG; protein kinase cAMP-activated catalytic subunit gamma
5136 PDE1A; phosphodiesterase 1A
5153 PDE1B; phosphodiesterase 1B
5137 PDE1C; phosphodiesterase 1C
5138 PDE2A; phosphodiesterase 2A
5139 PDE3A; phosphodiesterase 3A
5140 PDE3B; phosphodiesterase 3B
5141 PDE4A; phosphodiesterase 4A
5142 PDE4B; phosphodiesterase 4B
5143 PDE4C; phosphodiesterase 4C
5144 PDE4D; phosphodiesterase 4D
5150 PDE7A; phosphodiesterase 7A
27115 PDE7B; phosphodiesterase 7B
8622 PDE8B; phosphodiesterase 8B
5151 PDE8A; phosphodiesterase 8A
10846 PDE10A; phosphodiesterase 10A
50940 PDE11A; phosphodiesterase 11A
134 ADORA1; adenosine A1 receptor
|
K04215 OPRM1; mu-type opioid receptor
K04144 DRD1; dopamine receptor D1
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K15015 SLC32A; solute carrier family 32 (vesicular inhibitory amino acid transporter)
K04997 KCNJ3; potassium inwardly-rectifying channel subfamily J member 3
K05000 KCNJ6; potassium inwardly-rectifying channel subfamily J member 6
K05002 KCNJ9; potassium inwardly-rectifying channel subfamily J member 9
K04999 KCNJ5; potassium inwardly-rectifying channel subfamily J member 5
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05175 GABRA; gamma-aminobutyric acid receptor subunit alpha
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05186 GABRG; gamma-aminobutyric acid receptor subunit gamma
K05186 GABRG; gamma-aminobutyric acid receptor subunit gamma
K05186 GABRG; gamma-aminobutyric acid receptor subunit gamma
K05184 GABRD; gamma-aminobutyric acid receptor subunit delta
K05185 GABRE; gamma-aminobutyric acid receptor subunit epsilon
K05192 GABRQ; gamma-aminobutyric acid receptor subunit theta
K05189 GABRP; gamma-aminobutyric acid receptor subunit pi
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
K05190 GABRR; gamma-aminobutyric acid receptor subunit rho
K04615 GABBR; gamma-aminobutyric acid type B receptor
K04615 GABBR; gamma-aminobutyric acid type B receptor
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K04536 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04537 GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
K07825 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
K04538 GNB4; guanine nucleotide-binding protein subunit beta-4
K04539 GNB5; guanine nucleotide-binding protein subunit beta-5
K07826 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04540 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
K04541 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04544 GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
K04545 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04548 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1
K04549 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K00910 ADRBK; beta-adrenergic-receptor kinase [EC:2.7.11.15]
K00910 ADRBK; beta-adrenergic-receptor kinase [EC:2.7.11.15]
K08291 GRK4_5_6; G protein-coupled receptor kinase [EC:2.7.11.16]
K08291 GRK4_5_6; G protein-coupled receptor kinase [EC:2.7.11.16]
K08291 GRK4_5_6; G protein-coupled receptor kinase [EC:2.7.11.16]
K04439 ARRB; beta-arrestin
K04439 ARRB; beta-arrestin
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K19663 PRKCG; classical protein kinase C gamma type [EC:2.7.11.13]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K13755 PDE1; calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
K18283 PDE2A; cGMP-dependent 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
K19021 PDE3A; cGMP-inhibited 3',5'-cyclic phosphodiesterase A [EC:3.1.4.17]
K13296 PDE3B; cGMP-inhibited 3',5'-cyclic phosphodiesterase B [EC:3.1.4.17]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K13293 PDE4; cAMP-specific phosphodiesterase 4 [EC:3.1.4.53]
K18436 PDE7; high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 [EC:3.1.4.53]
K18436 PDE7; high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 [EC:3.1.4.53]
K18437 PDE8; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8 [EC:3.1.4.53]
K18437 PDE8; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8 [EC:3.1.4.53]
K18438 PDE10; cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10 [EC:3.1.4.17 3.1.4.35]
K13298 PDE11; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 [EC:3.1.4.17 3.1.4.35]
K04265 ADORA1; adenosine receptor A1
|
05033 Nicotine addiction [PATH:hsa05033]
|
05034 Alcoholism [PATH:hsa05034]
|
|
|
09166 Cardiovascular disease
|
|
|
09167 Endocrine and metabolic disease
|
|
|
09175 Drug resistance: antimicrobial
|
|
|
09176 Drug resistance: antineoplastic
|
|
|
09180 Brite Hierarchies
|
|
|
09190 Not Included in Pathway or Brite
|